Cytokinetics share price

WebMar 16, 2024 · Cytokinetics, Incorporated Common Stock (CYTK) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. WebMar 2, 2024 · Cytokinetics ( NASDAQ: CYTK) announced its Q422 and FY22 results this week - in a press release, the company revealed: Net loss for the fourth quarter was …

Cytokinetics, Inc. (KK3A) Stock Price & News - Google Finance

WebView the latest Cytokinetics Inc. (CYTK) stock price, news, historical charts, analyst ratings and financial information from WSJ. WebApr 10, 2024 · Cytokinetics (Nasdaq:CYTK) - Stock Price, News & Analysis - Simply Wall St Stocks / United States / Pharmaceuticals & Biotech Cytokinetics NasdaqGS:CYTK … dating site headline examples https://mkbrehm.com

Analysts Have Conflicting Sentiments on These Healthcare …

WebNov 8, 2024 · The cap price of the capped call transactions will initially be approximately $14.07 per share, which represents a premium of approximately 70% over the per share closing price of Cytokinetics’s ... WebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors. Investors & Media Cytokinetics’ unparalleled expertise has … WebGet the latest Cytokinetics, Inc. (KK3A) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment … dating site harmony

Cytonics Company Profile: Valuation & Investors PitchBook

Category:Investors might be losing patience for Cytokinetics

Tags:Cytokinetics share price

Cytokinetics share price

CYTK Cytokinetics Inc. Stock Price & News - WSJ

WebAug 8, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 327% in the last half decade, a handsome return for long term holders. If that doesn't get you thinking about ... WebThe current Cytokinetics [ CYTK] share price is $43.11. The Score for CYTK is 56, which is 12% above its historic median score of 50, and infers lower risk than normal. CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Cytokinetics share price

Did you know?

WebDescription. Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary ... WebGenerating Revenue. 4. Later Stage VC. 02-Mar-2011. $1M. $3.3M. Completed. Generating Revenue. To view Cytonics’s complete valuation and funding history, request access ».

WebSep 23, 2024 · SOUTH SAN FRANCISCO, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the first participants have been dosed in a Phase 1 placebo ... WebApr 11, 2024 · According to the issued ratings of 12 analysts in the last year, the consensus rating for Cytokinetics stock is Moderate Buy based on the current 1 hold rating and 11 buy ratings for CYTK. The average twelve-month price prediction for Cytokinetics is $56.21 with a high price target of $80.00 and a low price target of $15.00.

WebMar 31, 2024 · On Friday 03/31/2024 the closing price of the Cytokinetics Inc share was $35.19 on NAS. Compared to the opening price on Friday 03/31/2024 on NAS of $35.02, this is a gain of 0.48%. WebCYTK - Cytokinetics Inc Stock quote - CNNMoney.com Markets Tech Media Success Video Cytokinetics Inc (NASDAQ:CYTK) Real-Time Quotes 35.31 BATS BZX Real …

WebFeb 24, 2024 · For example, the Cytokinetics, Incorporated (NASDAQ:CYTK) share price is up a whopping 442% in the last half decade, a handsome return for long term holders. And this is just one example of the epic gains achieved by some long term investors. On the other hand, the stock price has retraced 5.7% in the last week.

WebJul 1, 2024 · The initial conversion price represents a premium of 30.0% over the last reported sale price of $39.29 per share of Cytokinetics’ common stock on June 30, … bj\u0027s family bundlesWeb12 hours ago · Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635 (c) (4) 3 Best Stocks to Buy Now, 4/3/2024, According to Top Analysts … bj\u0027s family feastWebApr 13, 2024 · The projected fair value for Cytokinetics is US$38.04 based on 2 Stage Free Cash Flow to Equity Cytokinetics' US$34.05 share price indicates it is trading at similar levels as its fair value estimate dating site hingedWebGet Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. dating site headline quotesWebMar 31, 2024 · CYTK: Get the latest Cytokinetics stock price and detailed information including CYTK news, historical charts and realtime prices. Menu icon A vertical stack of … bj\u0027s family membershipWebCytokinetics Stock Is Surging. Heart-Drug Results Are Exciting Investors. Key Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-4.25 Market Cap $3.46 B Shares Outstanding 95.16 … bj\\u0027s fairlawn ohioWeb18 hours ago · The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator ... bj\\u0027s family pharmacy